Global News
1 Apr 2021
Mace Rothenberg joins Aulos Bioscience Board of Directors
Dr Rothenberg will contribute substantial strategic expertise in oncology drug development Aulos Bioscience, a biotechnology company developing highly differentiated interleukin-2…
